Speech-Language Pathologists in Medical Lake, WA Accepting Medicare

7 Speech-Language Pathologists found. Showing 1 - 7

Torrance Whitney Baldwin, MS SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 116 West 3rd St., Medical Lake, WA 99022 Phone: 509-565-3145

Mrs. Keri Lea Wissink, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 116 West Thrird Street, Medical Lake, WA 99022 Phone: 509-565-3145

Ms. Christin Jean Knechtges, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 541 S Evergreen Dr, Medical Lake, WA 99022 Phone: 509-368-1867

Summer Gibby, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1105 N Olson Hill Ct, Medical Lake, WA 99022 Phone: 509-270-1829

Leah Marie Koch, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 317 N Broad St, Medical Lake, WA 99022 Phone: 509-565-3426

Jennifer L Marshall, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 116 W. Third Street, Medical Lake, WA 99022 Phone: 509-565-3100

Marcia L Ryan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 800 West Maple Street, Medical Lake, WA 99022 Phone: 509-299-3121    Fax: 509-299-7015

News Archive

Study: Previous COVID-19 infection does not completely protect against reinfection in young people

A past COVID-19 infection does not completely protect against reinfection in young people, according to an observational study of more than 3,000 healthy members of the US Marines Corps most of whom were aged 18-20 years, published in The Lancet Respiratory Medicine journal.

Young women smokers have highest risk of major heart attack than non-smoking peers, study shows

WOMEN smokers under the age of 50 are nearly 13 times more likely to suffer a major heart than non-smokers even if they are fit and healthy, according to new research led by Sheffield Teaching Hospitals NHS Foundation Trust.

meridianEMR launches UROAnalytics tool

meridianEMR, Inc., a leading provider of electronic health records systems and advanced healthcare analytics for urology and surgical practices, today has announced the launch of its exclusive multi-dimensional clinical analysis tool – UROAnalytics.

Savient announces pricing of $200 million 4.75% Convertible Senior Notes due 2018

Savient Pharmaceuticals, Inc. announced it has priced $200 million aggregate principal amount of 4.75% Convertible Senior Notes due 2018 (the "Notes") pursuant to an automatically effective registration statement filed with the Securities and Exchange Commission on January 31, 2011. In addition, Savient has granted the underwriters an option to purchase up to an additional $30 million aggregate principal amount of Notes, solely to cover over-allotments.

Study finds new therapeutic target to prevent progression of rare blood cancer

In a laboratory study, Upstate Medical University researcher Golam Mohi, Ph.D., his graduate student Yue Yang, and colleagues, have found that the loss of gene EZH2 promotes the development of Myelofibrosis (MF) in mice.

Read more Medical News

› Verified 3 days ago